Association Study of a Nicotinic Receptor Variant with Schizophrenic Disorders
- 1 January 2001
- journal article
- Published by S. Karger AG in Neuropsychobiology
- Vol. 43 (1) , 15-18
- https://doi.org/10.1159/000054859
Abstract
Nicotine acetylcholine receptors (nAChRs) are implicated in the pathogenesis of schizophrenia because the prevalence of smoking among schizophrenic patients is extraordinarily high, and nicotine has been demonstrated to improve some psychophysiological dysfunction in schizophrenics. In addition, recent studies have suggested linkage of the α7 nAChR gene region in families of schizophrenics. In a population-based association study, we tested the hypothesis that the allelic variant, with a 2-bp deletion, of the human α7 nAChR gene confers susceptibility to schizophrenic disorders. We genotyped α7 nAChR in 146 patients with schizophrenic disorders and 151 controls. The results showed no significant difference in genotype or allele frequencies between schizophrenic patients and control subjects. This suggests that α7 nAChR 2-bp deletion plays no major role in the pathogenesis of schizophrenic disorders. Other nAChR variants in schizophrenic disorders may need further investigation.Keywords
This publication has 4 references indexed in Scilit:
- Brief research communication: No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia familiesAmerican Journal of Medical Genetics, 1998
- Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locusProceedings of the National Academy of Sciences, 1997
- Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patientsSchizophrenia Research, 1994
- Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenicsBiological Psychiatry, 1992